CAS 1332331-08-4

3H-1,2,4-Triazol-3-one, 4-[4-(5-benzofuranyl)phenyl]-5-[[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl]-2,4-dihydro-

CAS: 1332331-08-4

Fórmula: C₂₅H₂₄N₄O₃

Pureza: 97%

Forma y color: Solid

Peso molecular: 428.4831

Ref: IN-DA0014FS

GSK2194069

CAS: 1332331-08-4

GSK2194069

Pureza: ≥98%

Peso molecular: 428.48g/mol

Ref: 54-BUP22027

GSK2194069

CAS: 1332331-08-4

GSK2194069: Fatty acid synthase inhibitor, β-keto reductase-specific, IC50 7.7 nM, hampers cancer cell proliferation.

Fórmula: C₂₅H₂₄N₄O₃

Pureza: 98.759% - 99.84%

Forma y color: Solid

Peso molecular: 428.48

Ref: TM-T15429

(S)-4-(4-(Benzofuran-5-yl)phenyl)-3-((1-(cyclopropanecarbonyl)pyrrolidin-3-yl)methyl)-1H-1,2,4-triazol-5(4H)-one

CAS: 1332331-08-4

Versatile small molecule scaffold

Fórmula: C₂₅H₂₄N₄O₃

Pureza: Min. 95%

Forma y color: Powder

Peso molecular: 428.49 g/mol

Ref: 3D-HDC33108